Effective targeting of pathogenic Acanthamoeba castellanii of the T4 genotype using nano-formulations of Quercetin

Abstract

The incidence of infections caused by pathogenic Acanthamoeba is increasing, yet the prognosis continues to be poor. Acanthamoeba spp. are responsible for causing a blinding keratitis and a fatal granulomatous amoebic encephalitis. Due to limited options for the treatment of Acanthamoeba infections, there is a need for the development of effective drugs, which can target Acanthamoeba species. Zinc-copper nanoparticles show antimicrobial effects and enhance the effectiveness of their payload at specified biological targets. In this study, we used Quercetin and its' nanoconjugates and tested their anti-acanthamoebic properties. Quercetin was conjugated and loaded onto tragacanth polymer (a bioadhesive gum) coated with zinc copper bimetallic nanoparticles (QUE-TRG-ZnCuNPs) to enhance effects against Acanthamoeba castellanii. The characterization of the nanoconjugates was accomplished through fourier-transform infrared spectroscopy, ultraviolet visible spectrophotometry. Zeta potential, particle size, polydispersity index, scanning electron microscopy with energy-dispersive X-ray analysis were accomplished. Quercetin alone and its nanoconjugates were tested for the viability and growth of amoeba, encystation and excystation activity against A. castellanii, the cytopathogenicity assays were conducted to understand amoebae-mediated cytopathogenicity on host cells. The findings revealed that QUE-TRG-ZnCuNPs displayed significant anti-amoebic properties, including encystation and excystment and enhanced the effects of Quercetin against A. castellanii. Furthermore, QUE-TRG-ZnCuNPs reduced amoebae-mediated cytopathogenicity on host cells. Thus, Quercetin, combined with nanotechnology, could provide an effective strategy in the rationale development of therapeutics against Acanthamoeba infections.

Article information

Article type
Paper
Submitted
28 Jul 2025
Accepted
16 Sep 2025
First published
23 Sep 2025
This article is Open Access
Creative Commons BY-NC license

RSC Pharm., 2025, Accepted Manuscript

Effective targeting of pathogenic Acanthamoeba castellanii of the T4 genotype using nano-formulations of Quercetin

R. Siddiqui, M. Kawish, S. H. Khan, S. Habib, M. R. Shah, T. Shahrul Anuar, E. Brown and N. A. Khan, RSC Pharm., 2025, Accepted Manuscript , DOI: 10.1039/D5PM00201J

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements